When the thrill is gone

Peter, Jamie St.
January 2007
Pharmaceutical Representative;Jan2007, Vol. 37 Issue 1, p23
The article discusses tips for pharmaceutical representatives on how to make their presentation to a doctor interesting. It is important to generate excitement about a product the representative has been selling for some time. It is important to regain the passion in selling. It is also important to give physicians the information they need to help their patients feel better.


Related Articles

  • To Sell Their Drugs. Hensley, Scott // Gerson Healing Newsletter;Sep/Oct2005, Vol. 20 Issue 5, p6 

    Reports on the growing reliance of U.S. pharmaceutical companies on the product endorsement of physicians. Utilization of part-time lectures to sell the products of drug companies; Criticisms being faced by drug makers regarding their conventional sales tactics; Attitude of physicians towards...

  • Sales detective. Leeds, Dorothy // Pharmaceutical Representative;Apr2006, Vol. 36 Issue 4, p41 

    The article provides a questioning strategy to be used by pharmaceutical representatives for asking doctors why they do not prescribe the representatives' products. The author suggests that representatives should consider themselves as detectives and use probing questions with purpose. Better...

  • Web Watch. McKillen, Dan // Medical Marketing & Media;Mar2004, Vol. 39 Issue 3, p24 

    Reports on the increasing number of physicians who participate in e-detailing sessions or online pharmaceutical marketing programs. Reasons why most doctors do not want pharmaceutical firms to know their identity; Benefits provided by e-detailing to the drug advertising market.

  • Rebuttal to Attack Against Bioidentical Hormones. Faloon, William // Life Extension;2009 Collector's Edition, p71 

    The article offers information on powerful economic bias against bioidentical hormones. It states that the pharmaceutical company's only hope to boosts sales is to spread deceptive information that will scare the public and turn doctors against replenishment of natural hormone. A study authors...

  • AMERICA'S Other DRUG PROBLEM. Zoellner, Tom // Men's Health;Oct2001, Vol. 16 Issue 8, p118 

    Talks about the efforts of drug companies to market their products to physicians in the United States. Amount spent by drug companies to persuade doctors into buying their products in 2000; Side effect of the priority approval process to certain critical medications, administered by the Food...

  • The Ten Billion Dollar Molecule. Maggon, Krishan // Pharmaceutical Executive;Nov2003, Vol. 23 Issue 11, p60 

    Outlines the key factors which contribute to the marketability and salability of several types of drugs in the U.S. List and ranking of the best-selling drugs and biologics and their manufacturer; Comparison of the sales levels for several types of drugs; Profits of the companies involved and...

  • Research & Markets: Pharmaceutical Key Trends 2011 - Biosimilar Market Overview: Biosmilar Uptake Set to Accelerate.  // Biomedical Market Newsletter;4/30/2011, p897 

    The article reports on the publication of the report on global biosimilars market by Dublin, Ireland-based Research & Markets Ltd. The report titled "Pharmaceutical Key Trends 2011: Prescription Pharmaceutical Sales Overview" provides prescription pharmaceutical sales growth trends and profiles...

  • Following the Script: How Drug Reps Make Friends and Influence Doctors. Fugh-Berman, Adriane; Ahari, Shahram // PLoS Medicine;Apr2007, Vol. 4 Issue 4, pe150 

    This article, which grew out of conversations between a former drug rep and a physician who researches pharmaceutical marketing, reveals the strategies used by reps to manipulate physician prescribing.

  • Troubles beset 'Jan Aushadhi' plan to broaden access to generics. Jayaraman, Killugudi // Nature Medicine;Apr2010, Vol. 16 Issue 4, p350 

    The article offers information on the 'Jan Aushadhi' or 'people's drug stores' program of India which aims to sell low priced generics or quality medicines across the nation. It states that with the launch of the plan, multinational pharmaceutical corporations are trying their best to protect...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics